Caris Life Sciences Inc. Share Price Today: Live Updates & Key Insights

Caris Life Sciences Inc. share price today is $18.77, up -2.13%. The stock opened at $18.71 against the previous close of $18.81, with an intraday high of $19.135 and low of $17.945.

Caris Life Sciences Inc. Share Price Chart

Caris Life Sciences Inc.

us-stock
To Invest in {{usstockname}}
us-stock

Caris Life Sciences Inc. Share Price Performance

$18.77 -0.0213(-2.13%) CAI at 23 Mar 2026 12:22 PM Biotechnology
Lowest Today 17.945
Highest Today 19.135
Today’s Open 18.71
Prev. Close 18.81
52 Week High 42.50
52 Week Low 17.15
Day’s Range: Low 17.945 High 19.135
52-Week Range: Low 17.15 High 42.50
1 day return -
1 Week return -3.41
1 month return +4.24
3 month return -35.24
6 month return -43.98
1 year return -34.02
3 year return -
5 year return -
10 year return -

Caris Life Sciences Inc. Institutional Holdings

Caris Life Sciences Inc. Market Status

Caris Life Sciences Inc. Fundamentals

Market Cap 5202.30 M

PB Ratio 9.0113

PE Ratio 0.0

Enterprise Value 4831.41 M

Total Assets 1125.66 M

Volume 8271308

Caris Life Sciences Inc. Company Financials

About Caris Life Sciences Inc. & investment objective

Company Information Caris Life Sciences, Inc., an artificial intelligence TechBio company, provides molecular profiling services in the United States and internationally. It develops and commercializes solutions to transform healthcare using molecular information, and artificial intelligence/machine learning algorithms. The company's molecular intelligence product portfolio includes MI Profile Platform, a whole exome sequencing (WES)/ whole transcriptome sequencing (WTS) tissue-based molecular profiling solutions; Caris Assure Platform WES/WTS blood-based molecular profiling solutions; Precision Whole Genome Platform, a whole genome sequencing (WGS) blood- and tissue-based profiling solutions; and Caris Detect, a WGS-based multi-cancer early detection solution; Caris WGS MRD a WGS and digital droplet polymerase reaction-based minimal residual disease solution; and Caris ChromoSeq, a WGS and WTS based assay for therapy selection in hematological cancers. It also offers pharma research and development services comprising laboratory delivery, strategic data, and research services to biopharmaceutical customers. The company provides its precision oncology solutions to customers, such as hospitals, institutions and patients. The company was founded in 2008 and is headquartered in Irving, Texas.

Organisation Biotechnology

Employees 1846

Industry Biotechnology

CEO Dr. David Dean Halbert M.D.

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right

Caris Life Sciences Inc. FAQs

What is the share price of Caris Life Sciences Inc. today?

The current share price of Caris Life Sciences Inc. is $18.77.

Can I buy Caris Life Sciences Inc. shares in India?

Yes, Indian investors can buy Caris Life Sciences Inc. shares by opening an international trading and demat account with Motilal Oswal.

How to buy Caris Life Sciences Inc. shares in India?

You can easily invest in Caris Life Sciences Inc. shares from India by:

Can I buy fractional shares of Caris Life Sciences Inc.?

Yes, many platforms allow you to buy fractional shares starting from as low as $1.

What is the market capitalization value of Caris Life Sciences Inc.?

Caris Life Sciences Inc. has a market cap of $5202.30 M.

In which sector does Caris Life Sciences Inc. belong?

Caris Life Sciences Inc. operates in the Biotechnology sector.

What documents are required to invest in Caris Life Sciences Inc. stocks?

To invest, you typically need:

What is the PE and PB ratio of Caris Life Sciences Inc.?

The PE ratio of Caris Life Sciences Inc. is N/A and the PB ratio is 9.01.